Lipoprotein patterns in diet, sulphonylurea, and insulin treated diabetics. 1981

H J Lisch, and S Sailer

In order to study the lipoprotein pattern in diabetes mellitus, plasma lipoproteins were isolated by rate zonal centrifugation in 12 control subjects (median fasting blood glucose level: 80 mg/dl (range: 74-86)), 14 diabetic patients treated by diet alone 104 mg/dl (76-153), 27 patients treated by diet plus insulin (180 mg/dl (106-404)), and 32 patients treated by diet plus sulphonylurea [178 mg/dl (103-361)]. No significant differences of median relative body weight existed between the four groups. Neither the diabetic group on diet alone nor the insulin-treated group differed significantly from control subjects with respect to lipid and lipoprotein concentrations. Diabetics treated with diet plus sulphonylurea, however, differed significantly from the control group with regard to the following parameters (median and range); plasma triglycerides (210 [75-620) mg/dl; p less than 0.01)] and intermediate density lipoproteins (65 (10-338) mg/dl; p less than 0.05)) were higher; low density lipoproteins (236 (82-418) mg/dl; p less than 0.05)) and high density lipoproteins2 (HDL2) [51 (12-121) mg/dl; p less than 0.01)] concentrations were lower. When data from all 85 studied individuals were analysed together, significant positive correlations were observed between fasting blood glucose and plasma triglyceride concentration (r = 0.28, p less than 0.01), and between fasting blood glucose and plasma very low density lipoproteins (VLDL) (r = 0.23, p less than 0.05). A negative correlation was found between blood glucose and plasma HDL2 (r = -0.29, p less than 0.01). In addition, VLDL correlated negatively with HDL2 (r = -0.89, p less than 0.001) but not with plasma HDL3 concentration. It is concluded that the deranged lipoprotein metabolism in diabetes mellitus may be better controlled by insulin than by sulphonylureas.

UI MeSH Term Description Entries
D007328 Insulin A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1). Iletin,Insulin A Chain,Insulin B Chain,Insulin, Regular,Novolin,Sodium Insulin,Soluble Insulin,Chain, Insulin B,Insulin, Sodium,Insulin, Soluble,Regular Insulin
D008074 Lipoproteins Lipid-protein complexes involved in the transportation and metabolism of lipids in the body. They are spherical particles consisting of a hydrophobic core of TRIGLYCERIDES and CHOLESTEROL ESTERS surrounded by a layer of hydrophilic free CHOLESTEROL; PHOSPHOLIPIDS; and APOLIPOPROTEINS. Lipoproteins are classified by their varying buoyant density and sizes. Circulating Lipoproteins,Lipoprotein,Lipoproteins, Circulating
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D001786 Blood Glucose Glucose in blood. Blood Sugar,Glucose, Blood,Sugar, Blood
D001835 Body Weight The mass or quantity of heaviness of an individual. It is expressed by units of pounds or kilograms. Body Weights,Weight, Body,Weights, Body
D003920 Diabetes Mellitus A heterogeneous group of disorders characterized by HYPERGLYCEMIA and GLUCOSE INTOLERANCE.
D003927 Diet, Diabetic A course of food intake prescribed for patients, that limits the amount of foods with a high GLYCEMIC INDEX. Diabetic Diet,Diabetic Diets,Diets, Diabetic
D005260 Female Females
D005905 Glyburide An antidiabetic sulfonylurea derivative with actions like those of chlorpropamide Glibenclamide,Daonil,Diabeta,Euglucon 5,Euglucon N,Glybenclamide,HB-419,HB-420,Maninil,Micronase,Neogluconin,HB 419,HB 420,HB419,HB420

Related Publications

H J Lisch, and S Sailer
September 1989, Metabolism: clinical and experimental,
H J Lisch, and S Sailer
December 1983, The Tohoku journal of experimental medicine,
H J Lisch, and S Sailer
July 1981, British medical journal (Clinical research ed.),
H J Lisch, and S Sailer
September 1965, Lancet (London, England),
H J Lisch, and S Sailer
January 1982, Acta diabetologica latina,
H J Lisch, and S Sailer
July 1990, The Journal of the Association of Physicians of India,
H J Lisch, and S Sailer
November 1965, Lancet (London, England),
Copied contents to your clipboard!